Download Docs
Export

Elanco Animal Health and Bayer

C-4725 | Federal Trade Commission

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed July 15, 2020
Case Flags Manufacturing, Pharmaceuticals, Competition, Merger, Horizontal, Bureau of Competition, Regional Offices, and Northwest Region
FTC Matter/File Number 191 0198
Case Summary
In July 2020, the FTC required global suppliers of animal products, Elanco Animal Health, Inc. and Bayer Animal Health GmbH, to divest three animal health products to settle charges that Elanco’s proposed $7.6 billion acquisition of Bayer would likely be anticompetitive in those markets. On Sept. 11, 2020, the Commission announced the final consent agreement in this matter.
Case Type Administrative
Last Updated: 2 years, 11 months ago
Filing Date # Docket Text